FUREN Group Pharmaceutical Co., Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 349.32 million compared to CNY 494.1 million a year ago. Net loss was CNY 177.27 million compared to CNY 38.47 million a year ago. Basic loss per share from continuing operations was CNY 0.28 compared to CNY 0.06 a year ago.